Is now at
Argyll Park, Dixon, California
Argyll 

Home

Amylin reports total income of $152.

Amylin reports total income of $152.7 million for quarter ended March 31, 2011 Amylin Pharmaceuticals, Inc. today reported financial results for the quarter ended March 31, 2011 article . The Company reported total income of $152.7 million for the quarter ended March 31, 2011, which include net revenue of $150.8 million and revenues under collaborative agreements of $1.9 million. Non-GAAP operating loss was $3.2 million for the quarter ended March 31, 2011, compared to $3.8 million for the same period this year 2010. GAAP net loss was $37.3 million, or $0.26 per share, for the quarter ended March 31, 2011, compared to $38.2 million, or $0.27 per share, for the same period in 2010 2010.